Key Takeaways
- Pricing pressure crushed margins: EBITDA margin fell to 7% (Rs.22 crores) from 9.7% in Q1, driven by competitive import pricing and a U.S. tariff ripple that also hit export volumes.
- Anti-dumping petition is the near-term catalyst: The government found merit and initiated a detailed investigation; management is "reasonably confident" of a favorable finding, though quantum is unknown.
- Volume story is mixed: Domestic volumes grew sequentially, but exports declined and H1 volumes are down 5% YoY; management still expects full-year volumes to be positive.
- Self-help levers are in motion: Dahej TDQ capacity is 75–80% complete, operational efficiency measures should show results by Q4, and a new product soft launch is underway with commercial sales targeted before FY26-end.
- What to watch next quarter: The anti-dumping investigation outcome, whether pricing truly bottoms as management cautiously expects, and the pace of export volume recovery as U.S. tariff negotiations progress.
Pricing & Competitive Pressure
- Import dumping intensified: Korean players priced antioxidants below Chinese levels, partly benefiting from FTA advantages, though they offer only a single product versus NOCIL's full basket.
- U.S. tariff disruption: Pre-tariff, Europe dominated the U.S. market; post-tariff, Korea gained entry on one product while India had to cut prices to compete with Europe despite holding a duty advantage over China.
- Mystery competitor support: Some competitors appear to have government backing enabling them to sustain unrealistic pricing benchmarks, a dynamic management called "a mystery" and "a guess" rather than a confirmed fact.
- High-cost inventory drag nearly over: Over 90–95% of high-cost inventory has been exhausted; a small residual may remain given the industry's 60–70 day import cover structure.
- Pricing bottom uncertain: Management expressed "cautious optimism" that pricing is bottoming out based on upstream raw material trends, but explicitly noted they were wrong on this call a few quarters ago and are now reluctant to make a firm call.
Anand: "I stuck my neck out a few quarters ago and said I think it's bottomed out and then I was wrong. So I'm going to be cautious again because -- okay, again, I feel it's kind of bottoming out because I'm looking at upstream raw material trends and assume that further deflation should not happen."
Anti-Dumping Petition
- Petition filed on select products: The company filed anti-dumping petitions on key products with the Government of India; authorities found merit in the submissions and initiated a detailed investigation, with an outcome expected in the coming months.
- Intermediate product included: One petition covers an intermediate for rubber chemicals; the finished product made from that intermediate constitutes 30% of Indian demand.
- Volume and pricing support expected: If anti-dumping duty comes through, it should support both volume growth and pricing, though management cannot predict the quantum while the matter is sub judice.
- Strategy runs independent of ADD: Management emphasized that penetrating existing customers and expanding to newer markets is ongoing irrespective of anti-dumping duty support.
Srinivasan: "We are reasonably confident that we will get a favourable finding. But the quantum of finding, I don't think so — I mean, I cannot predict today."
Volume Performance & Outlook
| Channel | Trend | Commentary |
|---|---|---|
| Domestic | ▲ Sequential growth | Volume grew QoQ, but pricing remains under pressure from dumping; medium-to-long-term market share expected to creep up. |
| Exports | ▼ Declined | Hit by U.S. tariff ripple effect, cautious customer sentiment, and challenging demand in key geographies; expected to stay choppy for the next few months. |
| Latex | ▼ Degrowth | Production in key markets fell YoY due to tariff uncertainties, though those uncertainties are now resolving. |
| U.S. market | ▼ Holdback | Growth held back for now; company shifting focus to other geographies while customer negotiations continue. |
- Full-year volume positive despite H1: Management is positive that full-year volumes will stay positive by FY26-end, even though H1 volumes were down 5%.
- FY27 growth expected: Even if pricing pressure persists, management is positive there will be growth in FY27.
- Supply reliability push: NOCIL is evaluating potential stock points in international markets to enhance supply reliability for export customers.
Operational Efficiency & Cost Actions
- Working capital tightened: Operating cash flow improved, driven by a 20% improvement in sales number of days through better inventory management, production planning, and forecasting.
- Conversion cost reduction underway: Multiple measures (debottlenecking, steam/electricity/hydrogen consumption reduction) are in advanced stages and should show results before Q4 of this financial year; management calls the savings "sizable" but declined to quantify.
- Capacity utilization stuck at 65%: The plant was built for much higher capacity but volumes cannot be loaded due to competitive pressure; operational leverage benefits have scope to flow as volumes improve.
- Efficiency gains sustained: Management committed that efficiency improvements already achieved will be maintained or improved.
Growth Investments & New Products
- Dahej TDQ capacity on track: 75% to 80% of work is completed; commissioning and trial production are targeted for H1 calendar year 2026, somewhere in the January-to-June window.
- New product soft launch underway: Active commercial sales should start before the end of FY26; these are unique products not comparable to existing ones. Initial volumes will be limited until further customer approvals are obtained, and additional capacity will need to be built if successful.
Anand: "Already a soft launch is underway. More an active commercial sales of it should start before the end of this financial year. But... these will be initially limited volumes that we can do until we get more further approvals from customers, then we will need to build the additional capacities for those products given that they are successful and they are wanted by customers."
Financial Performance
| Metric | Q2 FY26 | Q1 FY26 | H1 FY26 | H1 FY25 |
|---|---|---|---|---|
| Revenue | Rs.321 Cr | Higher (sequential decline) | – | – |
| Operating EBITDA | Rs.22 Cr (7.0%) | Rs.31 Cr | Rs.53 Cr (8.1%) | Rs.79 Cr |
| PAT | – | – | Rs.29 Cr | Rs.69 Cr |
- Revenue decline driven by pricing: Softer realizations partially reflected easing raw material costs, but the larger factor was heightened competitive pricing pressure from imports.
- PAT halved YoY: H1 FY26 PAT at Rs.29 crores versus Rs.69 crores in H1 FY25, impacted by the business slump and a taxation credit that benefited the prior-year period.
- Operating cash flow improved: Reflects focused efforts on working capital efficiency, with corrective measures in inventory and receivables management.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Anti-dumping outcome | Favorable finding expected; quantum unknown | "Coming months" |
| Full-year volume growth | Volumes to be positive for FY26 despite H1 at minus 5% | By FY26-end |
| Dahej TDQ commissioning | Trial production to begin | H1 calendar year 2026 (Jan–Jun) |
| New product commercial sales | Active sales to begin | Before FY26-end |
| Operational efficiency results | Debottlenecking and consumption reduction measures to show results | Before Q4 FY26 |
| FY27 growth | Growth expected even if pricing pressure persists | FY27 |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Revenue | ₹321 cr, vs ₹336 cr in Q1 FY26 |
| H1 FY26 revenue | ₹657 cr, vs ₹735 cr in H1 FY25 |
| Sales volume index | 138 (Q1 FY20 base of 100), 4% QoQ growth |
| Operating EBITDA | ₹22 cr, vs ₹31 cr in Q1 FY26 |
| EBITDA margin | 7%, vs 8.1% in H1 FY26 |
| Operating PBT | ₹19 cr, vs ₹23 cr in Q1 FY26 |
| Profit after tax | ₹17 cr, flat QoQ |
| H1 FY26 profit after tax | ₹29 cr, vs ₹69 cr in H1 FY25 |
| Domestic market share | ~38–40%, of 80,000–85,000 tons annual demand |
| Capacity utilization | ~65% |
| H1 FY26 volume growth | –5% YoY |
| Domestic-to-export volume mix | ~2/3 domestic, 1/3 exports |
| Dahej capex completion | 75–80% complete, trial production expected H1 CY26 |
| Working capital days improvement | ~20% reduction in sales number of days |
| Latex/specialty share of volumes | ~8% of overall sales volumes |